8
P. WANG ET AL.
1
ꢁ
NMR (162 MHz, CDCl , H PO ): d ꢀ 54.77 ppm; H NMR
1i: MP 190–191 C; FTIR: ꢀ
3317 (N-H), 2937, 1751
max
3
3
4
ꢀ
1 31
(
400 MHz, CDCl , TMS): d (ppm) 0.96 (d, 6H, J ¼ 6.7 Hz, (C ¼ O), 1607, 1498 (Ar-H), 1263, 1001, 856, 693 cm
;
P
3
1
2
2
1
2
ꢃ CH ), 1.02 (d, 6H, J ¼ 6.9 Hz, 2 ꢃ CH ), 2.18–2.21 (m, NMR (162 MHz, CDCl , H PO ): d ꢀ 53.90 ppm; H NMR
3
3
3
3
4
2
H, 2 ꢃ CH), 2.94 (s, 6H, 2 ꢃ CH ), 3.68 (d, 2H, J
¼
(400 MHz, CDCl , TMS): d (ppm) 2.29 (dd, 2H, J ¼ 11.3 Hz,
3
H-N-P
3
6.5 Hz, 2 ꢃ NH), 3.77 (dd, 2H, J ¼ 8.5 Hz, J ¼ 2.9 Hz, J ¼ 13.5 Hz, 1 ꢃ CH ), 3.02 (s, 6H, 2 ꢃ CH ), 3.18 (d, 2H,
2
3
2
ꢃ CH), 6.40–6.42 (2H, Ar-H), 6.52 (d, 1H, J ¼ 8.4 Hz, Ar- J ¼ 13.6 Hz, 1 ꢃ CH ), 3.56 (d, 2H,
J
¼ 17.5 Hz,
2
H-N-P
13
H), 7.15 (t, 1H, J ¼ 8.0 Hz, Ar-H); C NMR (100 MHz, 2 ꢃ NH), 3.95–4.02 (m, 2H, 2 ꢃ CH), 6.54–6.62 (m, 3H, Ar-
1
3
CDCl , TMS): d (ppm) 16.4, 19.0, 30.7 (d, J ¼ 6.4 Hz), 40.4, H), 7.14–7.15 (m, 4H, Ar-H), 7.28–7.37 (m, 7H, Ar-H);
C
3
2
6
1
1
0.1 (d,
J
¼ 3.3 Hz) , 105.3 (d, J ¼ 5.1 Hz), 108.7, NMR (100 MHz, CDCl
3
, TMS): d (ppm) 39.6 (d, J ¼ 3.6 Hz),
C-N-P
2
09.2, 129.9 (d, J ¼ 2.1 Hz), 151.8, 152.5 (d, J ¼ 10.2 Hz), 40.5, 56.2 (d, JC-N-P ¼ 5.6 Hz), 109.7, 127.4, 129.0, 129.1,
2
þ
2
69.3 (d, J
¼ 11.5 Hz); HRMS (ESI): m/z [M þ H] , 129.4, 130.0, 136.5,152.1, 152.2, 169.2 (d,
J
C(O)-O-P
¼
C(O)-O-P
þ
þ
calcd for C H N O P 398.1839, found 398.1844.
11.9 Hz); HRMS (ESI): m/z [M þ H] , calcd for
1
8
19 3 5
þ
C H N O P 484.1839, found 494.1846.
2
6
29
3
5
Preparation of (3S,8S)-5-(3-(diethylamino)phenoxy)-3,8-diiso-
5
propyl-1,6-dioxa-4,9-diaza-5k -phosphaspiro[4.4]nonane-2,7-
Preparation of 2-((3S,8S)-3,8-diisopropyl-2,7-dioxo-1,6-dioxa-
5
dione 1g: The general procedure was followed using 1b 4,9-diaza-5k -phosphaspiro[4.4]nonan-5-yl)-N,N-diethylaceta-
131 mg, 0.5 mmol) and 3-(diethylamino) phenol (82.6 mg, mide 1j and 2-((3S,8S)-3,8-diisopropyl-2,7-dioxo-1,6-dioxa-
.5 mmol). The crude product was purified by column chro- 4,9-diaza-5k -phosphaspiro[4.4]nonan-5-yl)-N,N-diethylaceta-
(
0
5
matography (silica gel/PE: EA ¼ 5:1) to give 1g as a white mide 1k: To a stirred solution of compounds 1a (131 mg,
ꢁ
solid. MP 135–136 C; FTIR: ꢀ
3280 (N-H), 2963, 1732 0.5 mmol) and 2-chloro-N, N-diethylacetamide (74.8 mg,
max
ꢀ
1
31
1
(
(
(
C ¼ O), 1606, 1506, 1270, 836, 655 cm
;
P NMR 0.5 mmol) in CH
CN (5 mL), TBAI (2 mmol) and Cs CO
3 2 3
162 MHz, CDCl , H PO ): d ꢀ 54.47 ppm;
H
NMR (3 mmol) were added. The reaction mixture was stirred at
3
3
4
31
400 MHz, CDCl , TMS): d (ppm) 0.96 (d, 6H, J ¼ 6.8 Hz, room temperature until the P NMR signal of reactant 1a
3
2
ꢃ CH ), 1.02 (d, 6H, J ¼ 7.0 Hz, 2 ꢃ CH ), 1.16 (t, 6H, disappeared. Then the reaction solution was filtered and
3
3
J ¼ 7.04 Hz, 2 ꢃ CH ), 2.18–2.22 (m, 2H, 2 ꢃ CH), 3.32 (q, dried to obtain a crude product. The residue was purified by
3
2
4
2
H, J ¼ 7.08 Hz, 2 ꢃ CH ), 3.65 (d, 2H, J
¼ 15.96 Hz, column chromatography (silica gel/PE: EA ¼ 2:1) to give 1j
[11]
2
H-N-P
ꢃ NH), 3.77 (dd, 2H, J ¼ 8.4 Hz, J ¼ 2.6 Hz, 2 ꢃ CH), 6.32 and 1k as a white solid.
ꢁ
(
7
d, 2H, J ¼ 6.5 Hz, Ar-H), 6.46 (d, 1H, J ¼ 8.1 Hz, Ar-H),
1j: MP 130–132 C; FTIR: ꢀmax 3361 (N-H), 2981, 2918,
1
3
ꢀ1 31
.11 (t, 1H, J ¼ 8.4 Hz, Ar-H); C NMR (100 MHz, CDCl , 1750 (C ¼ O), 1642, 1506, 1270, 1235, 809 cm ;1 P NMR
3
TMS): d (ppm) 12.5, 16.4, 19.1, 30.7 (d, J ¼ 6.5 Hz), 44.4, (162 MHz, CDCl
,
H
PO
): d ꢀ 50.66 ppm;
H
NMR
3
3
4
2
6
0.1 (d, J
¼ 3.4 Hz), 104.6, 107.7, 108.7, 130.1, 149.2, (400 MHz, CDCl
3
, TMS): d (ppm) 0.94 (d, 6H, J ¼ 6.8 Hz,
), 1.11 (t, 3H,
), 1.21 (t, 3H, J ¼ 7.2 Hz, 1 ꢃ CH ),
C-N-P
2
1
(
52.7 (d, J ¼ 10.2 Hz), 169.3(d, J
¼ 11.2 Hz); HRMS 2 ꢃ CH
3
), 1.01 (d, 6H, J ¼ 7.0 Hz, 2 ꢃ CH
3
C(O)-O-P
þ
þ
ESI): m/z [M þ H] , calcd for C H N O P 426.2152, J ¼ 7.0 Hz, 1 ꢃ CH
20
33 3 5
3
3
found 426.2157.
2.13–2.20 (m, 2H, 2 ꢃ CH), 3.12–3.50 (m, 8H, 3 ꢃ CH
,
2
2
ꢃ NH), 3.88 (ddd, 2H, J ¼ 12.2 Hz, J ¼ 3.4 Hz, J ¼ 1.2 Hz),
13
Preparation of (3S,8S)-3,8-dibenzyl-5-(3-(dimethylamino)phe-
C NMR (100 MHz, CDCl , TMS): d (ppm) 12.8, 14.5, 16.7,
3
5
noxy)-1,6-dioxa-4,9-diaza-5k -phosphaspiro[4.4]nonane-2,7- 19.1, 30.8 (d, J ¼ 3.5 Hz), 38.8, 40.6 (d, J ¼ 23.35 Hz), 43.1,
2
dione 1h and (3S,8S)-3,8-dibenzyl-5-(3-(dimethylamino)phe- 60.3 (d, JC-N-P ¼ 3.5 Hz), 166.0 (d, J ¼ 6.3 Hz), 170.3 (d,
5
þ
noxy)-1,6-dioxa-4,9-diaza-5k -phosphaspiro[4.4]nonane-2,7- J ¼ 7.3 Hz); HRMS (ESI): m/z [M þ H] , calcd for
þ
dione 1i: The general procedure was followed using 1d
C
16
H
31
N
3
O
5
P 376.1996, found 376.1995.
ꢁ
(
0
179 mg, 0.5 mmol) and 3-(dimethylamino) phenol (68.6 mg,
1k: MP 130–132 C; FTIR: ꢀmax 3352 (N-H), 2963, 2918,
ꢀ
1
31
.5 mmol). The crude products were purified by column 1750 (C ¼ O), 1624, 1515, 1270, 1226, 800 cm ; P NMR
1
chromatography (silica gel/PE: EA ¼ 5:1) to give 1h and 1i (162 MHz, CDCl
as a white solid.
(400 MHz, CDCl
, TMS): d (ppm) 0.98 (d, 6H, J¼ 6.4 Hz,
h: MP 190–191 C; FTIR: ꢀ
), 1.7 (d, 6H, J¼ 6.6 Hz, 2ꢃ CH ), 1.13 (t, 3H,
P NMR J¼ 6.8 Hz, 1ꢃ CH ), 1.21 (t, 3H, J¼ 6.8 Hz, 1ꢃ CH ),
,
3
H PO ): d ꢀ 49.87 ppm;
3 4
H
NMR
3
ꢁ
1
3316 (N-H), 2918, 1741 2ꢃ CH
3
3
max
ꢀ
1
31
(
(
(
C ¼ O), 1597, 1506 (Ar-H), 1270, 855, 682 cm
;
3
3
1
162 MHz, CDCl , H PO ): d ꢀ 57.05 ppm;
H
NMR 2.19–2.24 (m, 2H, 2ꢃ CH), 3.19–3.67 (m, 10H, 3ꢃ CH
2
,
3
3
4
1
3
400 MHz, CDCl , TMS): d (ppm) 2.72 (dd, 2H, J ¼ 8.4 Hz, 2ꢃ NH, 2ꢃ CH), C NMR (100 MHz, CDCl
, TMS): d
3
3
J ¼ 13.8 Hz, 1 ꢃ CH ), 2.91 (s, 6H, 2 ꢃ CH ), 3.16 (dd, 2H, (ppm) 12.7, 14.4, 17.9, 19.4, 31.1 (d, J¼ 6.1 Hz), 40.4 (d,
2
3
2
2
J ¼ 3.0 Hz, J ¼ 13.8 Hz, 1 ꢃ CH ), 3.54 (d, 2H,
J
¼
J¼ 15.4 Hz), 42.0, 42.9, 60.0 (d, JC-N-P ¼ 2.9 Hz), 165.2 (d,
2
H-N-P
þ
1
2
6.9 Hz, 2 ꢃ NH), 4.00 (dt, 2H, J ¼ 3.6 Hz, J ¼ 8.6 Hz, J¼ 6.1 Hz), 170.3 (d, J¼ 5.9 Hz); HRMS (ESI): m/z [M þ Na] ,
þ
ꢃ CH), 6.28–6.50 (m, 4H, Ar-H), 7.10–7.15 (m, 5H, Ar- calcd for C16
H
30
N
NaO
P 398.1815, found 398.1831.
3
5
1
3
H), 7.29–7.38 (m, 5H, Ar-H); C NMR (100 MHz, CDCl ,
3
2
TMS): d (ppm) 39.3 (d, J ¼ 6.6 Hz), 40.4, 56.0 (d, J
¼
C-N-P
4
.2. Synthesis of 4x by the Michael addition reaction
4
1
.9 Hz), 105.1, 109.3, 127.4, 128.9, 129.4, 129.9, 130.1, 135.9,
2
52.2, 156.7, 169.1 (d, J
m/z [M þ H] , calcd for C H N O P
¼ 11.5 Hz); HRMS (ESI): General procedure: To a stirred solution of nitroolefin 2a
C(O)-O-P
þ
þ
484.1839, (0.5 mmol), malonate 3a (1 mmol) and Et NH (0.5 mmol) in
2
6
29
3
5
2
found 494.1846.
toluene was added catalyst 1f (10mmol%). After being stirred